Redmile Group’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
Other funds holding OCUL
SR
Redmile Group's OCUL Position: Q3 2026 in Review
Redmile Group opened a new position in Ocular Therapeutix (OCUL) in Q3 2026: 243,954 shares worth $1.87M. The stake represents 0.14% of the portfolio and ranks #42 among its holdings.
263 funds tracked by Wall St. Rank hold OCUL as of Q3 2026.
- Redmile Group held 243,954 shares of Ocular Therapeutix worth $1.87M as of Q3 2026.
- Ocular Therapeutix was a new Redmile Group position in Q3 2026.
- Ocular Therapeutix made up 0.14% of Redmile Group's portfolio in Q3 2026, its #42 holding.
- 263 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2026.
Based on Redmile Group's 13F filing for Q3 2026, filed 16 Nov 2026.